Bio-Rad Laboratories, Inc. (BIO)
USD 243.57
(4.85%)
USD 243.57
(4.85%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1 Billion USD | 31.15% |
| 2022 | 763.96 Million USD | 266.16% |
| 2021 | -459.78 Million USD | 29.06% |
| 2020 | -648.14 Million USD | -193.38% |
| 2019 | -220.92 Million USD | -2895.05% |
| 2018 | 7.9 Million USD | -84.56% |
| 2017 | 51.17 Million USD | 335.36% |
| 2016 | -21.74 Million USD | -0.93% |
| 2015 | -21.54 Million USD | -194.81% |
| 2014 | 22.72 Million USD | -78.53% |
| 2013 | 105.85 Million USD | -60.91% |
| 2012 | 270.77 Million USD | 71.07% |
| 2011 | 158.28 Million USD | 174.17% |
| 2010 | 57.73 Million USD | -38.0% |
| 2009 | 93.11 Million USD | -62.91% |
| 2008 | 251.03 Million USD | -15.1% |
| 2007 | 295.66 Million USD | 44.19% |
| 2006 | 205.06 Million USD | 54.98% |
| 2005 | 132.31 Million USD | -44.8% |
| 2004 | 239.7 Million USD | 173.58% |
| 2003 | 87.61 Million USD | 2.45% |
| 2002 | 85.52 Million USD | -43.45% |
| 2001 | 151.22 Million USD | -27.14% |
| 2000 | 207.55 Million USD | -14.97% |
| 1999 | 244.1 Million USD | 486.78% |
| 1998 | 41.6 Million USD | 6.67% |
| 1997 | 39 Million USD | 1244.83% |
| 1996 | 2.9 Million USD | -85.78% |
| 1995 | 20.4 Million USD | -53.74% |
| 1994 | 44.1 Million USD | -41.59% |
| 1993 | 75.5 Million USD | -17.58% |
| 1992 | 91.6 Million USD | -0.22% |
| 1991 | 91.8 Million USD | 33.24% |
| 1990 | 68.9 Million USD | 19.62% |
| 1989 | 57.6 Million USD | 17.31% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 985.39 Million USD | 1.97% |
| 2024 Q3 | 790.94 Million USD | -0.78% |
| 2024 Q1 | 966.38 Million USD | -3.55% |
| 2023 Q1 | 734.38 Million USD | -3.87% |
| 2023 Q4 | 1 Billion USD | 35.15% |
| 2023 FY | 1 Billion USD | 31.15% |
| 2023 Q3 | 741.33 Million USD | -8.35% |
| 2023 Q2 | 808.85 Million USD | 10.14% |
| 2022 Q4 | 763.96 Million USD | 12.38% |
| 2022 Q3 | 679.77 Million USD | 13.14% |
| 2022 Q2 | 600.82 Million USD | 52.14% |
| 2022 Q1 | 394.92 Million USD | 185.89% |
| 2022 FY | 763.96 Million USD | 266.16% |
| 2021 Q4 | -459.78 Million USD | 45.75% |
| 2021 FY | -459.78 Million USD | 29.06% |
| 2021 Q3 | -847.51 Million USD | -17.66% |
| 2021 Q2 | -720.32 Million USD | -9.0% |
| 2021 Q1 | -660.83 Million USD | -1.96% |
| 2020 FY | -648.14 Million USD | -193.38% |
| 2020 Q1 | -165.03 Million USD | 25.3% |
| 2020 Q2 | -168.84 Million USD | -2.31% |
| 2020 Q3 | -401.44 Million USD | -137.76% |
| 2020 Q4 | -648.14 Million USD | -61.45% |
| 2019 Q3 | -121.49 Million USD | 13.98% |
| 2019 Q4 | -220.92 Million USD | -81.84% |
| 2019 Q2 | -141.23 Million USD | -754.58% |
| 2019 FY | -220.92 Million USD | -2895.05% |
| 2019 Q1 | -16.52 Million USD | -309.1% |
| 2018 FY | 7.9 Million USD | -84.56% |
| 2018 Q4 | 7.9 Million USD | 30.47% |
| 2018 Q3 | 6.05 Million USD | -83.84% |
| 2018 Q2 | 37.49 Million USD | 34.98% |
| 2018 Q1 | 27.77 Million USD | -45.73% |
| 2017 FY | 51.17 Million USD | 335.36% |
| 2017 Q4 | 51.17 Million USD | -51.73% |
| 2017 Q3 | 106.03 Million USD | -6.42% |
| 2017 Q2 | 113.3 Million USD | -20.82% |
| 2017 Q1 | 143.09 Million USD | 758.08% |
| 2016 FY | -21.74 Million USD | -0.93% |
| 2016 Q3 | 16.49 Million USD | 5.06% |
| 2016 Q4 | -21.74 Million USD | -231.82% |
| 2016 Q2 | 15.7 Million USD | -48.79% |
| 2016 Q1 | 30.66 Million USD | 242.32% |
| 2015 Q2 | -14.2 Million USD | -239.31% |
| 2015 Q3 | -71.22 Million USD | -401.39% |
| 2015 FY | -21.54 Million USD | -194.81% |
| 2015 Q1 | 10.19 Million USD | -55.13% |
| 2015 Q4 | -21.54 Million USD | 69.75% |
| 2014 Q1 | 72.83 Million USD | -31.19% |
| 2014 Q3 | 12.61 Million USD | -76.04% |
| 2014 Q2 | 52.66 Million USD | -27.7% |
| 2014 FY | 22.72 Million USD | -78.53% |
| 2014 Q4 | 22.72 Million USD | 80.11% |
| 2013 Q2 | 367.49 Million USD | 0.5% |
| 2013 Q4 | 105.85 Million USD | -27.23% |
| 2013 Q3 | 145.45 Million USD | -60.42% |
| 2013 Q1 | 365.65 Million USD | 35.04% |
| 2013 FY | 105.85 Million USD | -60.91% |
| 2012 FY | 270.77 Million USD | 71.07% |
| 2012 Q1 | 198.89 Million USD | 25.66% |
| 2012 Q2 | 276.35 Million USD | 38.94% |
| 2012 Q3 | 306.08 Million USD | 10.76% |
| 2012 Q4 | 270.77 Million USD | -11.53% |
| 2011 Q1 | 113.57 Million USD | 96.73% |
| 2011 Q2 | 62.39 Million USD | -45.06% |
| 2011 Q3 | 61.37 Million USD | -1.63% |
| 2011 Q4 | 158.28 Million USD | 157.89% |
| 2011 FY | 158.28 Million USD | 174.17% |
| 2010 Q1 | 145.63 Million USD | 56.4% |
| 2010 FY | 57.73 Million USD | -38.0% |
| 2010 Q4 | 57.73 Million USD | -48.5% |
| 2010 Q3 | 112.09 Million USD | -13.68% |
| 2010 Q2 | 129.86 Million USD | -10.83% |
| 2009 Q2 | 210.85 Million USD | -18.14% |
| 2009 FY | 93.11 Million USD | -62.91% |
| 2009 Q1 | 257.59 Million USD | 2.61% |
| 2009 Q4 | 93.11 Million USD | -50.96% |
| 2009 Q3 | 189.85 Million USD | -9.96% |
| 2008 Q4 | 251.03 Million USD | -5.14% |
| 2008 Q2 | 271.72 Million USD | -17.32% |
| 2008 Q1 | 328.64 Million USD | 11.15% |
| 2008 FY | 251.03 Million USD | -15.1% |
| 2008 Q3 | 264.63 Million USD | -2.61% |
| 2007 Q3 | -41.74 Million USD | -121.04% |
| 2007 Q4 | 295.66 Million USD | 808.29% |
| 2007 Q1 | 199.79 Million USD | -2.57% |
| 2007 FY | 295.66 Million USD | 44.19% |
| 2007 Q2 | 198.36 Million USD | -0.72% |
| 2006 Q1 | 164.16 Million USD | 24.08% |
| 2006 FY | 205.06 Million USD | 54.98% |
| 2006 Q2 | 184.7 Million USD | 12.51% |
| 2006 Q3 | 191.1 Million USD | 3.46% |
| 2006 Q4 | 205.06 Million USD | 7.31% |
| 2005 Q2 | 185.21 Million USD | 57.54% |
| 2005 Q3 | 190.81 Million USD | 3.03% |
| 2005 Q4 | 132.31 Million USD | -30.66% |
| 2005 FY | 132.31 Million USD | -44.8% |
| 2005 Q1 | 117.56 Million USD | -50.95% |
| 2004 Q2 | 80.75 Million USD | -13.31% |
| 2004 Q4 | 239.7 Million USD | 119.28% |
| 2004 FY | 239.7 Million USD | 173.58% |
| 2004 Q1 | 93.15 Million USD | 6.32% |
| 2004 Q3 | 109.31 Million USD | 35.36% |
| 2003 Q3 | 94.06 Million USD | 12.62% |
| 2003 FY | 87.61 Million USD | 2.45% |
| 2003 Q1 | 84.78 Million USD | -0.86% |
| 2003 Q2 | 83.51 Million USD | -1.5% |
| 2003 Q4 | 87.61 Million USD | -6.85% |
| 2002 FY | 85.52 Million USD | -43.45% |
| 2002 Q3 | 110.25 Million USD | -18.28% |
| 2002 Q4 | 85.52 Million USD | -22.44% |
| 2002 Q1 | 139.49 Million USD | -7.76% |
| 2002 Q2 | 134.91 Million USD | -3.28% |
| 2001 FY | 151.22 Million USD | -27.14% |
| 2001 Q4 | 151.22 Million USD | -15.49% |
| 2001 Q3 | 178.94 Million USD | -3.78% |
| 2001 Q2 | 185.98 Million USD | -11.81% |
| 2001 Q1 | 210.89 Million USD | 1.61% |
| 2000 Q3 | 216.83 Million USD | -13.07% |
| 2000 Q4 | 207.55 Million USD | -4.28% |
| 2000 FY | 207.55 Million USD | -14.97% |
| 2000 Q1 | 256.54 Million USD | 5.1% |
| 2000 Q2 | 249.42 Million USD | -2.77% |
| 1999 Q1 | 43.2 Million USD | 3.85% |
| 1999 Q3 | 33.3 Million USD | -11.44% |
| 1999 Q4 | 244.1 Million USD | 633.03% |
| 1999 Q2 | 37.6 Million USD | -12.96% |
| 1999 FY | 244.1 Million USD | 486.78% |
| 1998 Q2 | 44.7 Million USD | 1.59% |
| 1998 Q4 | 41.6 Million USD | 2.97% |
| 1998 FY | 41.6 Million USD | 6.67% |
| 1998 Q1 | 44 Million USD | 12.82% |
| 1998 Q3 | 40.4 Million USD | -9.62% |
| 1997 Q4 | 39 Million USD | 766.67% |
| 1997 Q1 | 5.8 Million USD | 100.0% |
| 1997 Q2 | 3.2 Million USD | -44.83% |
| 1997 Q3 | 4.5 Million USD | 40.63% |
| 1997 FY | 39 Million USD | 1244.83% |
| 1996 Q1 | 13.1 Million USD | -35.78% |
| 1996 Q2 | 900 Thousand USD | -93.13% |
| 1996 Q3 | 3.4 Million USD | 277.78% |
| 1996 Q4 | 2.9 Million USD | -14.71% |
| 1996 FY | 2.9 Million USD | -85.78% |
| 1995 FY | 20.4 Million USD | -53.74% |
| 1995 Q1 | 42.1 Million USD | -4.54% |
| 1995 Q2 | 38.7 Million USD | -8.08% |
| 1995 Q3 | 32.4 Million USD | -16.28% |
| 1995 Q4 | 20.4 Million USD | -37.04% |
| 1994 Q2 | 55.4 Million USD | -14.37% |
| 1994 Q4 | 44.1 Million USD | -15.03% |
| 1994 FY | 44.1 Million USD | -41.59% |
| 1994 Q1 | 64.7 Million USD | -14.3% |
| 1994 Q3 | 51.9 Million USD | -6.32% |
| 1993 Q1 | 93 Million USD | 1.53% |
| 1993 Q2 | 100.1 Million USD | 7.63% |
| 1993 Q3 | 96.2 Million USD | -3.9% |
| 1993 Q4 | 75.5 Million USD | -21.52% |
| 1993 FY | 75.5 Million USD | -17.58% |
| 1992 Q4 | 91.6 Million USD | 3.74% |
| 1992 FY | 91.6 Million USD | -0.22% |
| 1992 Q1 | 91.9 Million USD | 0.11% |
| 1992 Q2 | 104.1 Million USD | 13.28% |
| 1992 Q3 | 88.3 Million USD | -15.18% |
| 1991 Q4 | 91.8 Million USD | 3.96% |
| 1991 Q1 | 72.4 Million USD | 5.08% |
| 1991 Q2 | 74.9 Million USD | 3.45% |
| 1991 Q3 | 88.3 Million USD | 17.89% |
| 1991 FY | 91.8 Million USD | 33.24% |
| 1990 FY | 68.9 Million USD | 19.62% |
| 1990 Q2 | 58.9 Million USD | 7.29% |
| 1990 Q3 | 61.2 Million USD | 3.9% |
| 1990 Q4 | 68.9 Million USD | 12.58% |
| 1990 Q1 | 54.9 Million USD | -4.69% |
| 1989 FY | 57.6 Million USD | 17.31% |
| 1989 Q4 | 57.6 Million USD | 5.88% |
| 1989 Q3 | 54.4 Million USD | -1.98% |
| 1989 Q2 | 55.5 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 88.839% |
| Allurion Technologies Inc. | 3.82 Million USD | -26128.508% |
| Artivion, Inc. | 300.4 Million USD | -233.531% |
| Avanos Medical, Inc. | 121.4 Million USD | -725.312% |
| Butterfly Network, Inc. | -109.6 Million USD | 1014.094% |
| Butterfly Network, Inc. | -109.6 Million USD | 1014.094% |
| Boston Scientific Corporation | 8.62 Billion USD | 88.386% |
| CONMED Corporation | 966.95 Million USD | -3.617% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 323.097% |
| Paragon 28, Inc. | 36.39 Million USD | -2653.233% |
| Glaukos Corporation | 290.27 Million USD | -245.17% |
| Globus Medical, Inc. | 53.11 Million USD | -1786.446% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 723.513% |
| Integer Holdings Corporation | 1.01 Billion USD | 1.509% |
| Medtronic plc | 24.76 Billion USD | 95.954% |
| Myomo, Inc. | -6.27 Million USD | 16079.721% |
| Nevro Corp. | 117.61 Million USD | -751.908% |
| Owlet, Inc. | -1.34 Million USD | 74815.119% |
| Penumbra, Inc. | 66.85 Million USD | -1398.615% |
| Vicarious Surgical Inc. | -37.99 Million USD | 2737.349% |
| Smith & Nephew plc | 2.78 Billion USD | 63.985% |
| Sonendo, Inc. | 26.34 Million USD | -3703.542% |
| STERIS plc | 3.17 Billion USD | 68.455% |
| Stryker Corporation | 10.02 Billion USD | 90.005% |
| Vapotherm, Inc. | 102.66 Million USD | -875.902% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 82.042% |